Search Count: 8
 |
Organism: Severe acute respiratory syndrome coronavirus 2, Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2024-03-27 Classification: VIRAL PROTEIN/IMMUNE SYSTEM Ligands: NAG |
 |
Sars-Cov-2 S Ntd (C.37 Lambda Variant) Plus S2L20 And S2X303 Fabs, Local Refinement
Organism: Severe acute respiratory syndrome coronavirus 2, Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2024-03-27 Classification: VIRAL PROTEIN/IMMUNE SYSTEM Ligands: NAG |
 |
Organism: Homo sapiens, Severe acute respiratory syndrome coronavirus 2
Method: ELECTRON MICROSCOPY Release Date: 2024-03-27 Classification: VIRAL PROTEIN/IMMUNE SYSTEM Ligands: NAG |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: ELECTRON MICROSCOPY Release Date: 2023-04-05 Classification: VIRAL PROTEIN Ligands: NAG |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: ELECTRON MICROSCOPY Release Date: 2023-04-05 Classification: VIRAL PROTEIN Ligands: NAG |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: ELECTRON MICROSCOPY Release Date: 2023-04-05 Classification: VIRAL PROTEIN Ligands: NAG |
 |
Original Engineered Variant Of I-Onui Meganuclease Targeting The Hiv Integrase Gene; Harbors 49 Point Mutations Relative To Wild-Type I-Onui
Organism: Synthetic construct
Method: X-RAY DIFFRACTION Resolution:2.40 Å Release Date: 2017-09-27 Classification: HYDROLASE/DNA Ligands: CA |
 |
Engineered Variant Of I-Onui Meganuclease Targeting The Hiv Integrase Gene; Harbors 47 Point Mutations Relative To Wild-Type I-Onui
Organism: Synthetic construct
Method: X-RAY DIFFRACTION Resolution:2.15 Å Release Date: 2017-05-03 Classification: HYDROLASE/DNA Ligands: CA |